Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation SequencingInvivoscribe Marketing2021-04-27T17:17:21-07:00April 20th, 2021|2021 Publications, Publications| Read more
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality TestingInvivoscribe Marketing2021-02-17T18:10:07-08:00November 17th, 2020|2020 Publications, Featured Publications, Publications| Read more
Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation SequencingInvivoscribe Marketing2021-02-11T21:47:46-08:00May 19th, 2020|2020 Publications, Publications| Read more
Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaInvivoscribe Marketing2021-02-11T21:50:38-08:00May 1st, 2020|2020 Publications, Publications| Read more
Monitoring minimal residual disease in the bone marrow using next generation sequencingInvivoscribe Marketing2021-02-11T22:00:56-08:00January 17th, 2020|2020 Publications, Publications| Read more
Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaInvivoscribe Marketing2021-02-15T20:01:10-08:00June 6th, 2019|2019 Publications, Publications| Read more
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutationsInvivoscribe Marketing2021-02-11T23:49:39-08:00August 25th, 2018|2018 Publications, Featured Publications, Publications| Read more
Invivoscribe Expands Ion PGM NGS Platform Menu: Releases Additional CE-IVD Clonality Kits with Bioinformatics Software and RUO Kits with MRD Softwarewmm2021-02-26T19:13:58-08:00February 28th, 2017|2017 Press Releases, Press Releases| Read more
Invivoscribe Announces Long-Term Collaboration Agreement with Illumina and Plans Release of NGS-based IVD Assay Kitswmm2021-02-26T19:14:04-08:00February 14th, 2017|2017 Press Releases, Press Releases| Read more
Invivoscribe Expands Long-Term Collaboration Agreement to Release FLT3 Mutation and Clonality Assay Kitswmm2021-02-26T19:14:11-08:00January 31st, 2017|2017 Press Releases, Press Releases| Read more
Ion Torrent Developers Alliance Program Designed to Speed Targeted NGS Assay Developmentwmm2021-02-26T19:14:30-08:00May 31st, 2016|2016 Press Releases, Press Releases| Read more